semaglutide launch date Novo Nordisk's shortage officially concludes in the US, spelling major threat for weight loss drug compounders Novo Nordisk's Wegovy® HD available

GLP-1 Analogues Strategic Business Report 2026: Market to Reach $122.3 Billion by 2030 from $45.3 Billion in 2025 - Strong Pipeline Activity and Strategic Partnerships Fuel Innovations Key opportunities in the GLP-1 Analogues market include surging demand due to escalating diabetes and obesity rates, enhanced drug innovations (e.g., oral formulations), and significant growth in regions like the U.S

We believe the best outcomes come from aligning science, expertise, and personalization

Increasing frequency of unplanned eating or snacking

Ready When You Are Request an appointment and well talk through your energy, weight, hormones, and goals, and the program that fits

Retatrutide Pharmacokinetics Retatrutide Half-Life: What the Phase 2 Data Actually Shows Retatrutide has a half-life of approximately 6 days, according to the Phase 2 trial published in the New England Journal of Medicine (Jastreboff et al., 2023)

S.Pratt-PhillipsS.GonzalezL